Author： Neidecker Marjorie V.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.27, Iss.6, 2009-06, pp. : 451-464
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacoeconomic Considerations in Treating Ovarian Cancer
By Bodurka-Bevers D. Sun C.C. Gershenson D.M.
PharmacoEconomics, Vol. 17, Iss. 2, 2000-02 ,pp. :
Access to resources
Recommend
Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia
By Jønsson V.
PharmacoEconomics, Vol. 15, Iss. 2, 1999-02 ,pp. :
Emerging drugs for actinic keratosis
By Ulrich Martina Drecoll Ulrike Stockfleth Eggert
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
Pharmacotherapy of actinic keratosis
By Berman Brian Amini Sadegh Valins Whitney Block Samantha
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. :